MDM2 vs MDM4: dependency and drugs side by side
MDM2 vs MDM4 in DepMap 24q4 Chronos data and drug annotations: 384 of 1178 cell lines depend on MDM2, 142 on MDM4; 12 drugs listed for MDM2, 1 for MDM4.
BioQ Blog
Every BioQ post about CRISPR dependency: real search results, sources and the query to repeat it.
MDM2 vs MDM4 in DepMap 24q4 Chronos data and drug annotations: 384 of 1178 cell lines depend on MDM2, 142 on MDM4; 12 drugs listed for MDM2, 1 for MDM4.
JAK2 vs TYK2 in DepMap and drug databases: 8 of 1178 cell lines are dependent on JAK2, 11 on TYK2; 47 drugs are known for JAK2 and 20 for TYK2.
BTK vs ITK compared in DepMap Chronos data and drug annotations: BTK is a dependency in 5 of 1178 cell lines, ITK in none; 30 drugs versus 4 listed.
How to check tumour versus normal expression of a gene across 24 cancer types with one ERBB2 query, using TCGA/GTEx Toil data plus DepMap dependency.
RET is not a broad CRISPR dependency in DepMap, yet 29 drugs and 1873 disease links exist; one BioQ query reads seven public resources as of 2026-11-06.
PRMT5 is a common-essential gene in DepMap Chronos data, has 3 listed drugs, and 453 Open Targets diseases; one BioQ query joins all the layers.
How to get the pathway and protein interaction context of a gene in one BioQ query, shown for PIK3CA with Reactome, STRING v12 and DepMap data.
EGFR vs ERBB2 in DepMap Chronos data and drug annotations: 224 of 1178 EGFR-dependent lines versus 177 for ERBB2, and 118 versus 59 known drugs.
CDK4 vs CDK6 in DepMap and drug data: 786 of 1178 cell lines depend on CDK4, 595 on CDK6, and four approved drugs are annotated to both genes.